Figure 7 | Laboratory Investigation

Figure 7

From: Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl4-induced advanced cirrhosis

Figure 7

Hepatic expression of cannabinoid type 1 (CB1) and CB2 receptors. (a, b) Hepatic CB1 and CB2 receptor gene expression and (c, d) densitometric quantification (upper) plus representative images (lower) of western blot analysis of CB1 and CB2 receptor protein expression in healthy rats (CT), in pre-ascitic cirrhotic rats (CHBasal) and in rats receiving the vehicle (CHVehicle) or 10 mg/kg/day of the CB1-antagonist Rimonabant (CHRimonabant) for 2 additional weeks. Data are expressed as mean±s.e.

Back to article page